Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Windecker

Showing results (821-830 of 1,417) with videos related to

Pageof 142
Sort By:
Circulation. Cardiovascular Interventions|November 12, 2017
Predicting Mortality After Transcatheter Aortic Valve Replacement: External Validation of the Transcatheter Valve Therapy Registry ModelThomas Pilgrim, Anna Franzone, Stefan Stortecky, et al.
Plos One|March 29, 2014
Quality of care after acute coronary syndromes in a prospective cohort with reasons for non-prescription of recommended medicationsReto Auer, Baris Gencer, Lorenz Räber, et al.
Lancet (London, England)|September 2, 2018
Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trialThomas Pilgrim, Raffaele Piccolo, Dik Heg, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 2, 2023
Comparison of endothelial shear stress between ultrathin strut bioresorbable polymer drug-eluting stent vs durable-polymer drug-eluting stent post-stent implantation: An optical coherence tomography substudy from BIOFLOW IISolomon Beyene, Vincenzo Tufaro, Mohil Garg, et al.
Circulation. Cardiovascular Interventions|March 30, 2012
The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stentsThomas Pilgrim, Florian Vetterli, Bindu Kalesan, et al.
Cardiovascular Diabetology|November 2, 2019
Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61Patric Winzap, Allan Davies, Roland Klingenberg, et al.
Circulation. Cardiovascular Interventions|October 26, 2018
Unselected Use of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent for Coronary RevascularizationKyohei Yamaji, Thomas Zanchin, Christian Zanchin, et al.
Plos One|February 22, 2019
Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare interventionDavid Carballo, Nicolas Rodondi, Reto Auer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 5, 2015
Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillationSteffen Gloekler, Samera Shakir, Janosch Doblies, et al.
European Journal of Internal Medicine|May 4, 2024
Consecutive or selectively included high bleeding risk patients in the MASTER DAPT screening log and trialAntonio Landi, Dik Heg, Enrico Frigoli, et al.
Pageof 142

Showing results (821-830 of 1,417) with videos related to

Sort By:
Pageof 142
Circulation. Cardiovascular Interventions|November 12, 2017
Predicting Mortality After Transcatheter Aortic Valve Replacement: External Validation of the Transcatheter Valve Therapy Registry ModelThomas Pilgrim, Anna Franzone, Stefan Stortecky, et al.
Plos One|March 29, 2014
Quality of care after acute coronary syndromes in a prospective cohort with reasons for non-prescription of recommended medicationsReto Auer, Baris Gencer, Lorenz Räber, et al.
Lancet (London, England)|September 2, 2018
Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trialThomas Pilgrim, Raffaele Piccolo, Dik Heg, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 2, 2023
Comparison of endothelial shear stress between ultrathin strut bioresorbable polymer drug-eluting stent vs durable-polymer drug-eluting stent post-stent implantation: An optical coherence tomography substudy from BIOFLOW IISolomon Beyene, Vincenzo Tufaro, Mohil Garg, et al.
Circulation. Cardiovascular Interventions|March 30, 2012
The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stentsThomas Pilgrim, Florian Vetterli, Bindu Kalesan, et al.
Cardiovascular Diabetology|November 2, 2019
Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61Patric Winzap, Allan Davies, Roland Klingenberg, et al.
Circulation. Cardiovascular Interventions|October 26, 2018
Unselected Use of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent for Coronary RevascularizationKyohei Yamaji, Thomas Zanchin, Christian Zanchin, et al.
Plos One|February 22, 2019
Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare interventionDavid Carballo, Nicolas Rodondi, Reto Auer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 5, 2015
Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillationSteffen Gloekler, Samera Shakir, Janosch Doblies, et al.
European Journal of Internal Medicine|May 4, 2024
Consecutive or selectively included high bleeding risk patients in the MASTER DAPT screening log and trialAntonio Landi, Dik Heg, Enrico Frigoli, et al.
Pageof 142